Skip to main content
. 2024 Oct 31;6(5):339–344. doi: 10.35772/ghm.2024.01050

Table 3. Prevalence of symptoms related to perimenopausal syndrome among survey respondents [number/(proportion/%)].

Syndrome Patient group
Control group
χ 2 p
Yes No Yes No
Sweating and hot flashes 89 (40.5) 131 (59.5) 91 (37.3) 153 (62.7) 0.486 0.486
Paresthesia 97 (44.1) 123 (55.9) 76 (31.1) 168 (68.9) 8.289 0.004
Insomnia 147 (66.8) 73 (33.2) 132 (54.1) 112 (45.9) 7.808 0.005
Palpitations 148 (67.3) 72 (32.7) 122 (50.0) 122 (50.0) 14.187 < 0.001
Irritability 183 (83.2) 37 (16.8) 169 (69.3) 75 (30.7) 12.241 < 0.001
Depression 111 (50.5) 109 (49.5) 92 (37.7) 152 (62.3) 7.642 0.006
Arthralgia myalgia 150 (68.2) 70 (31.8) 150 (61.5) 94 (38.5) 2.277 0.131
Vertigo 144 (65.5) 76 (34.5) 147 (60.2) 97 (39.8) 1.342 0.247
Fatigue 175 (79.5) 45 (20.5) 141 (57.8) 103 (42.2) 25.214 < 0.001
Headache 140 (63.6) 80 (36.4) 144 (59.0) 100 (41.0) 1.040 0.308
Tingling sensation on the skin 58 (26.4) 162 (73.6) 41 (16.8) 203 (83.2) 6.300 0.012
Urinary system infections 51 (23.2) 169 (76.8) 37 (15.2) 207 (84.8) 4.839 0.028
Sexual problems 149 (67.7) 71 (32.3) 145 (59.4) 99 (40.6) 3.434 0.064